Transplantation of exogenous bone marrow mesenchymal stem cells by endocardium injection for treatment of acute myocardial infarction

CHENG Rui,WANG Shiwen,ZHANG Yourong,XU Yong,MENG Ling,WANG Yunfang,LI Yanhua,PEI Xuetao
DOI: https://doi.org/10.3969/j.issn.1001-1439.2007.09.016
2007-01-01
Journal of Clinical Cardiology
Abstract:Objective:To evaluate the therapeutic effect of intramyocardial transplantation with exogenous bone marrow mesenchymal stem cells (MSCs) in the setting of acute myocardial infarction.Method:Acute myocardial infarction was induced by ligating the left anterior descending coronary artery (LAD) in swine. Mesenchymal stem cells (MSCs) were freshly isolated from the bone marrow blood by 1.077 g/ml density-gradient centrifugation. 2-3 weeks after cultured in the complete cell-culturing medium, the purified exogenous MSCs or no serum medium were transplanted into target ischemia endocardium by reconstructed injection catheter. LV function was estimated by echocardiogram and blood biochemistry after 3 months transplantation. Desmin and cardiac-specific cardiac troponin I (cTnI) was examined with immunohischemistry method around infracted region after 3 months transplantation.Result:MSCs were harvested (3.81±0.09)×107 cells after cultured three generations over 2-3 weeks. DAPI-labeled MSCs in 1ml medium and medium only were multi-sites injected into the ischemia LAD territory with injection catheter. Left ventricular ejection fractions were (56.7±0.8)% ,(40.1±1.2)%,(34.9±0.9)% (P<0.05) at 3 months in transplantation group, control group and post-AMI respectively. The function of liver and kidney, blood glucose, artery blood gas analysis were normal after transplan tation. The positive stains of transplanted cells, desmin and cTnI were found in infarct myocardium at three month after transplantation.Conclusion:The therapy of generated exogenous MSCs transplantation is safe and effective.
What problem does this paper attempt to address?